Clinical trial · Interventional
Improving Implementation of Lung Cancer Screening in Diverse Populations II
NCT05265897CI-TRIAL-00056895completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project assesses the feasibility, appropriateness, and acceptability of a "Commonly Asked Questions after Lung Cancer Screening" (CAQ) informational document that the investigators created, resulting from patient and provider discussion in focus groups and interviews. If effective, the CAQ may be a new tool to help improve patient understanding of LCS results and adherence to follow-up recommendations.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early Detection of Cancer | Lung Neoplasm | PROBABILISTIC | 0.70 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CAQ | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Usual Care
- description
- Brief form letter with lung cancer screening results
- type
- EXPERIMENTAL
- label
- CAQ
- description
- Usual care, plus "Commonly Asked Questions after Lung Cancer Screening" informational document (CAQ)
- interventionNames
- Other: CAQ
Primary outcomes (4)
- measure
- Patient Understanding
- timeFrame
- 1 week post-randomization
- description
- Ratings of "I understand the results of my most recent LCS CT scan" on a Likert Scale
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Has undergone LCS or is referred for LCS * Able to give informed consent Exclusion Criteria: * Cognitive or language limitations (i.e., expressive language limitations, non-English speaking * Known malignancy other than non-melanoma skin cancer
References
Publications (1)
- DERIVEDTriplette M, Kross EK, Snidarich M, Shahrir S, Hippe DS, Crothers K. An alternating-intervention pilot trial on the impact of an informational handout on patient-reported outcomes and follow-up after lung cancer screening. PLoS One. 2024 Apr 10;19(4):e0300352. doi: 10.1371/journal.pone.0300352. eCollection 2024. PMID 38598511